LSV Asset Management trimmed its stake in Cabot Corporation (NYSE:CBT – Free Report) by 1.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 592,700 shares of the specialty chemicals company’s stock after selling 9,900 shares during the period. LSV Asset Management’s holdings in Cabot were worth $39,284,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of CBT. NewEdge Advisors LLC boosted its stake in Cabot by 2,559.5% during the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the period. Goldman Sachs Group Inc. boosted its stake in Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after purchasing an additional 108,645 shares during the period. Empowered Funds LLC boosted its stake in Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after purchasing an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Cabot by 3.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after purchasing an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. boosted its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Mizuho increased their price target on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Jefferies Financial Group reiterated a “buy” rating and set a $85.00 price target on shares of Cabot in a research note on Wednesday, February 4th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Finally, UBS Group increased their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Cabot presently has a consensus rating of “Hold” and a consensus target price of $80.25.
Cabot Stock Up 0.0%
CBT stock opened at $83.42 on Monday. Cabot Corporation has a one year low of $58.33 and a one year high of $86.43. The stock has a market capitalization of $4.31 billion, a PE ratio of 15.77, a price-to-earnings-growth ratio of 10.91 and a beta of 0.78. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The company has a fifty day moving average of $75.88 and a 200-day moving average of $71.38.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.31 million. During the same quarter last year, the business earned $1.90 EPS. The business’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, analysts expect that Cabot Corporation will post 6.32 EPS for the current year.
Cabot Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be paid a $0.4725 dividend. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. Cabot’s dividend payout ratio (DPR) is 34.03%.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
- Five stocks we like better than Cabot
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
